Vanderbilt Bill Wilkerson Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss	Deafness, Deafness, Autosomal Recessive 9, Ear Diseases, Hearing Loss, Bilateral, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, auditory neuropathy, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease	Recruiting	Phase 3	2026-09-29		NCT05821959
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma	Ear Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neurologic Manifestations, Otorhinolaryngologic Neoplasms, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, acoustic neuroma, cranial nerve neoplasm, cranial nerve neuropathy, hearing disorder, hearing loss disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroma, otorhinolaryngologic disease, peripheral nervous system neoplasm, primitive neuroectodermal tumor, retrocochlear disease, schwannoma, vestibulocochlear nerve disorder	Recruiting	Phase 1 / Phase 2	2026-04-06		NCT06517888

Clinical trials